Paulus Stoffels Biography and Net Worth

VP of Johnson & Johnson

Paul studied Medicine at the University of Diepenbeek and the University of Antwerp in Belgium and Infectious Diseases and Tropical Medicine at the Institute of Tropical Medicine in Antwerp, Belgium.
Paul began his career as a physician in Africa, focusing on HIV and tropical diseases clinical research, and worked at Janssen Pharmaceutica under the tutelage of Dr. Paul Janssen in the early 1990s. He re-joined Johnson & Johnson in 2002 with the acquisition of Virco and Tibotec, where he led the development of several breakthrough products for the treatment of HIV that helped to transform this devastating, deadly disease into a chronic and treatable condition.

What is Paulus Stoffels' net worth?: The estimated net worth of Paulus Stoffels is at least $58.56 million as of February 15th, 2018. Dr. Stoffels owns 357,906 shares of Johnson & Johnson stock worth more than $58,564,159 as of March 28th. This net worth evaluation does not reflect any other assets that Dr. Stoffels may own. Learn More about Paulus Stoffels' net worth.
How do I contact Paulus Stoffels?: The corporate mailing address for Dr. Stoffels and other Johnson & Johnson executives is ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK NJ, 08933. Johnson & Johnson can also be reached via phone at (732) 524-0400 and via email at investor-relations@its.jnj.com. Learn More on Paulus Stoffels' contact information.
Has Paulus Stoffels been buying or selling shares of Johnson & Johnson?: Paulus Stoffels has not been actively trading shares of Johnson & Johnson in the last ninety days. Most recently, Paulus Stoffels sold 155,342 shares of the business's stock in a transaction on Thursday, February 15th. The shares were sold at an average price of $129.86, for a transaction totalling $20,172,712.12. Following the completion of the sale, the vice president now directly owns 357,906 shares of the company's stock, valued at $46,477,673.16. Learn More on Paulus Stoffels' trading history.
Who are Johnson & Johnson's active insiders?: Johnson & Johnson's insider roster includes Dominic Caruso (VP), Robert Decker (CAO), Joaquin Duato (CEO & Chairman), Peter Fasolo (VP), Alex Gorsky (CEO), William Hait (Insider), Ronald Kapusta (CAO), Ashley McEvoy (EVP), Thibaut Mongon (VP), William Perez (Director), Timothy Schmid (EVP, Worldwide Chairman, MedTech), Michael Sneed (COO), Paulus Stoffels (VP), James Swanson (EVP), Jennifer Taubert (EVP), Mark Weinberger (Director), Kathryn Wengel (EVP), Joseph Wolk (CFO), and Joseph Wolk (Exec. VP & CFO ). Learn More on Johnson & Johnson's active insiders.
Are insiders buying or selling shares of Johnson & Johnson?: During the last year, Johnson & Johnson insiders bought shares 1 times. They purchased a total of 1,000 shares worth more than $147,220.00. During the last year, insiders at the sold shares 3 times. They sold a total of 13,037 shares worth more than $2,154,035.67. The most recent insider tranaction occured on February, 25th when VP Robert J Decker sold 6,999 shares worth more than $1,160,994.12. Insiders at Johnson & Johnson own 0.2% of the company. Learn More about insider trades at Johnson & Johnson.
Information on this page was last updated on 2/25/2025.

Paulus Stoffels Insider Trading History at Johnson & Johnson

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/15/2018	Sell	155,342	$129.86	$20,172,712.12	357,906
7/24/2017	Sell	102,692	$133.14	$13,672,412.88	230,342
2/15/2017	Sell	22,000	$117.29	$2,580,380.00	127,650
2/17/2016	Sell	125,000	$102.43	$12,803,750.00	122,543
4/28/2015	Sell	187,250	$100.73	$18,861,692.50
7/25/2013	Sell	45,440	$92.40	$4,198,656.00

Paulus Stoffels Buying and Selling Activity at Johnson & Johnson

Johnson & Johnson Company Overview

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Today's Range

Now: $163.63

$162.91

$164.52

50 Day Range

MA: $158.68

$145.39

$167.57

2 Week Range

Now: $163.63

$140.68

$169.99

Volume

5,760,266 shs

Average Volume

7,625,268 shs

Market Capitalization

$394.32 billion

P/E Ratio

24.61

Dividend Yield

3.08%

Beta

0.47